Natera (NTRA) Shares Outstanding (2014 - 2026)
Natera's (NTRA) quarterly Shares Outstanding (Entity) came in at $143.6 million in Q2 2026, up 5.01% on a YoY basis from $136.8 million in Q2 2025, and up 0.62% quarter-over-quarter from $142.7 million in Q1 2026.
Analysis
Natera (NTRA) Shares Outstanding (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Shares Outstanding (Entity) for 13 consecutive years, with $143.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 5.01% year-over-year to $143.6 million; the trailing twelve-month figure through Jun 2026 stood at $143.6 million (up 5.01% YoY), and the FY2025 full-year result was $139.7 million, up 5.31% from the prior year.
- Shares Outstanding (Entity) rose to $143.6 million in Q2 2026 per NTRA's latest filing, from $142.7 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $143.6 million in Q2 2026 and bottomed at $96.3 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $122.6 million across 5 years, with a median of $122.8 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) climbed 2.92% in 2022, then climbed 22.29% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $111.3 million in 2022, then grew by 7.48% to $119.6 million in 2023, then grew by 10.93% to $132.6 million in 2024, then increased by 5.31% to $139.7 million in 2025, then advanced by 2.81% to $143.6 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $143.6 million, $142.7 million, and $139.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 143.28 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 111.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 81.70 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 132.87 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 179.92 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 282.89 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 285.77 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 46.40 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 159.86 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 32.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143.28 Mn |
| Mar 31, 2026 | 141.50 Mn |
| Dec 31, 2025 | 136.72 Mn |
| Sep 30, 2025 | 137.19 Mn |
| Jun 30, 2025 | 136.39 Mn |
| Mar 31, 2025 | 134.75 Mn |
| Dec 31, 2024 | 124.72 Mn |
| Sep 30, 2024 | 123.78 Mn |
| Jun 30, 2024 | 122.85 Mn |
| Mar 31, 2024 | 120.81 Mn |
| Dec 31, 2023 | 115.00 Mn |
| Sep 30, 2023 | 115.17 Mn |
| Jun 30, 2023 | 113.69 Mn |
| Mar 31, 2023 | 111.77 Mn |
| Dec 31, 2022 | 98.41 Mn |
| Sep 30, 2022 | 97.05 Mn |
| Jun 30, 2022 | 96.58 Mn |
| Mar 31, 2022 | 95.58 Mn |
| Dec 31, 2021 | 90.56 Mn |
| Sep 30, 2021 | 92.56 Mn |